Modalis Therapeutics (4883.TSE) Q1 2025 Earnings

13FebConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-14
-10
-6
-1

Details

Expected EPS
N/A
Actual EPS
-1
Surprise EPS
-1
Surprise Percent
+∞%

Description

Modalis Therapeutics (4883.TSE) has reported earnings of -1 per share for Q1 2025.

0 Comments

Share your thoughts